ATN-224 enhances antitumor efficacy of oncolytic herpes virus against both local and metastatic head and neck squamous cell carcinoma

Head and neck squamous cell carcinoma (HNSCC) is the sixth most frequent cancer worldwide, and the 5-year survival rates are among the worst of the major cancers. Oncolytic herpes simplex viruses (oHSV) have the potential to make a significant impact in the targeted treatment of these patients. Here...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Ji Young, Yu, Jun-Ge, Kaka, Azeem, Pan, Quintin, Kumar, Pawan, Kumar, Bhavna, Zhang, Jianying, Mazar, Andrew, Teknos, Theodoros N, Kaur, Balveen, Old, Matthew O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782961/
https://www.ncbi.nlm.nih.gov/pubmed/27119105
http://dx.doi.org/10.1038/mto.2015.8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782961/
https://www.ncbi.nlm.nih.gov/pubmed/27119105
http://dx.doi.org/10.1038/mto.2015.8

Ejemplares similares